APO Research
Talk to an analyst

APO RESEARCH · REPORT

Osteoarthritis Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Osteoarthritis Drugs Industry Growth and Trends Forecast to 2032

20 December 202598 pages

Choose your research edition.

Industry ResearchOsteoarthritis Drugs Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Osteoarthritis Drugs Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal Osteoarthritis Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Osteoarthritis Drugs Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Osteoarthritis Drugs Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Osteoarthritis Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Osteoarthritis Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Osteoarthritis Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Osteoarthritis Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Osteoarthritis Drugs include Flexion Therapeutics, GlaxoSmithKline, Pfizer, Eli Lilly, Johnson & Johnson, Sanofi and Abbott, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Osteoarthritis Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Osteoarthritis Drugs market size, estimates, and forecasts are presented in terms of sales volume (kg) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Osteoarthritis Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Osteoarthritis Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Osteoarthritis Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Osteoarthritis Drugs Market by Company

Flexion Therapeutics

GlaxoSmithKline

Pfizer

Eli Lilly

Johnson & Johnson

Sanofi

Abbott

Osteoarthritis Drugs Segment by Type

Injection

External

Oral

Osteoarthritis Drugs Segment by Application

Online Pharmacies

Hospital Pharmacies

Retail Pharmacies

Osteoarthritis Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Osteoarthritis Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Osteoarthritis Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Osteoarthritis Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Osteoarthritis Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Osteoarthritis Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Injection Table 2. Major Company of External Table 3. Major Company of Oral Table 4. Global Osteoarthritis Drugs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Osteoarthritis Drugs Sales by Type (2021-2026) & (kg) Table 6. Global Osteoarthritis Drugs Sales Market Share in Volume by Type (2021-2026) Table 7. Global Osteoarthritis Drugs Sales by Type (2021-2026) & (US$ Million) Table 8. Global Osteoarthritis Drugs Sales Market Share in Value by Type (2021-2026) Table 9. Global Osteoarthritis Drugs Price by Type (2021-2026) & (US$/kg) Table 10. Global Osteoarthritis Drugs Sales by Type (2027-2032) & (kg) Table 11. Global Osteoarthritis Drugs Sales Market Share in Volume by Type (2027-2032) Table 12. Global Osteoarthritis Drugs Sales by Type (2027-2032) & (US$ Million) Table 13. Global Osteoarthritis Drugs Sales Market Share in Value by Type (2027-2032) Table 14. Global Osteoarthritis Drugs Price by Type (2027-2032) & (US$/kg) Table 15. North America Osteoarthritis Drugs Sales by Type (2021-2026) & (kg) Table 16. North America Osteoarthritis Drugs Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Osteoarthritis Drugs Sales by Type (2021-2026) & (kg) Table 18. Europe Osteoarthritis Drugs Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Osteoarthritis Drugs Sales by Type (2021-2026) & (kg) Table 20. Asia-Pacific Osteoarthritis Drugs Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Osteoarthritis Drugs Sales by Type (2021-2026) & (kg) Table 22. Latin America Osteoarthritis Drugs Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Osteoarthritis Drugs Sales by Type (2021-2026) & (kg) Table 24. Middle East and Africa Osteoarthritis Drugs Sales by Type (2021-2026) & (US$ Million) Table 25. Osteoarthritis Drugs Industry Trends Table 26. Osteoarthritis Drugs Industry Drivers Table 27. Osteoarthritis Drugs Industry Opportunities and Challenges Table 28. Osteoarthritis Drugs Industry Restraints Table 29. Global Osteoarthritis Drugs Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Osteoarthritis Drugs Revenue Market Share by Company (2021-2026) Table 31. Global Osteoarthritis Drugs Sales by Company (2021-2026) & (kg) Table 32. Global Osteoarthritis Drugs Sales Share by Company (2021-2026) Table 33. Global Osteoarthritis Drugs Market Price by Company (2021-2026) & (US$/kg) Table 34. Global Osteoarthritis Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Osteoarthritis Drugs Major Company Production Sites and Headquarters Table 36. Global Osteoarthritis Drugs Company, Product Type & Application Table 37. Global Osteoarthritis Drugs Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Osteoarthritis Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Osteoarthritis Drugs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Osteoarthritis Drugs Sales by Region (2021-2026) & (kg) Table 42. Global Osteoarthritis Drugs Sales Market Share in Volume by Region (2021-2026) Table 43. Global Osteoarthritis Drugs Sales by Region (2021-2026) & (US$ Million) Table 44. Global Osteoarthritis Drugs Sales Market Share in Value by Region (2021-2026) Table 45. Global Osteoarthritis Drugs Sales (kg), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 46. Global Osteoarthritis Drugs Sales by Region (2027-2032) & (kg) Table 47. Global Osteoarthritis Drugs Sales Market Share in Volume by Region (2027-2032) Table 48. Global Osteoarthritis Drugs Sales by Region (2027-2032) & (US$ Million) Table 49. Global Osteoarthritis Drugs Sales Market Share in Value by Region (2027-2032) Table 50. Global Osteoarthritis Drugs Sales (kg), Value (US$ Million), Price (US$/kg) and Gross Margin (2027-2032) Table 51. Global Osteoarthritis Drugs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Osteoarthritis Drugs Sales by Application (2021-2026) & (kg) Table 53. Global Osteoarthritis Drugs Sales Market Share in Volume by Application (2021-2026) Table 54. Global Osteoarthritis Drugs Sales by Application (2021-2026) & (US$ Million) Table 55. Global Osteoarthritis Drugs Sales Market Share in Value by Application (2021-2026) Table 56. Global Osteoarthritis Drugs Price by Application (2021-2026) & (US$/kg) Table 57. Global Osteoarthritis Drugs Sales by Application (2027-2032) & (kg) Table 58. Global Osteoarthritis Drugs Sales Market Share in Volume by Application (2027-2032) Table 59. Global Osteoarthritis Drugs Sales by Application (2027-2032) & (US$ Million) Table 60. Global Osteoarthritis Drugs Sales Market Share in Value by Application (2027-2032) Table 61. Global Osteoarthritis Drugs Price by Application (2027-2032) & (US$/kg) Table 62. North America Osteoarthritis Drugs Sales by Application (2021-2026) & (kg) Table 63. North America Osteoarthritis Drugs Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Osteoarthritis Drugs Sales by Application (2021-2026) & (kg) Table 65. Europe Osteoarthritis Drugs Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Osteoarthritis Drugs Sales by Application (2021-2026) & (kg) Table 67. Asia-Pacific Osteoarthritis Drugs Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Osteoarthritis Drugs Sales by Application (2021-2026) & (kg) Table 69. Latin America Osteoarthritis Drugs Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Osteoarthritis Drugs Sales by Application (2021-2026) & (kg) Table 71. Middle East and Africa Osteoarthritis Drugs Sales by Application (2021-2026) & (US$ Million) Table 72. Flexion Therapeutics Company Information Table 73. Flexion Therapeutics Business Overview Table 74. Flexion Therapeutics Osteoarthritis Drugs Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 75. Flexion Therapeutics Osteoarthritis Drugs Product Portfolio Table 76. Flexion Therapeutics Recent Development Table 77. GlaxoSmithKline Company Information Table 78. GlaxoSmithKline Business Overview Table 79. GlaxoSmithKline Osteoarthritis Drugs Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 80. GlaxoSmithKline Osteoarthritis Drugs Product Portfolio Table 81. GlaxoSmithKline Recent Development Table 82. Pfizer Company Information Table 83. Pfizer Business Overview Table 84. Pfizer Osteoarthritis Drugs Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 85. Pfizer Osteoarthritis Drugs Product Portfolio Table 86. Pfizer Recent Development Table 87. Eli Lilly Company Information Table 88. Eli Lilly Business Overview Table 89. Eli Lilly Osteoarthritis Drugs Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 90. Eli Lilly Osteoarthritis Drugs Product Portfolio Table 91. Eli Lilly Recent Development Table 92. Johnson & Johnson Company Information Table 93. Johnson & Johnson Business Overview Table 94. Johnson & Johnson Osteoarthritis Drugs Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 95. Johnson & Johnson Osteoarthritis Drugs Product Portfolio Table 96. Johnson & Johnson Recent Development Table 97. Sanofi Company Information Table 98. Sanofi Business Overview Table 99. Sanofi Osteoarthritis Drugs Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 100. Sanofi Osteoarthritis Drugs Product Portfolio Table 101. Sanofi Recent Development Table 102. Abbott Company Information Table 103. Abbott Business Overview Table 104. Abbott Osteoarthritis Drugs Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 105. Abbott Osteoarthritis Drugs Product Portfolio Table 106. Abbott Recent Development Table 107. North America Osteoarthritis Drugs Market Size Growth Rate (CAGR) by Country (kg): 2021 VS 2025 VS 2032 Table 108. North America Osteoarthritis Drugs Sales by Country (2021-2026) & (kg) Table 109. North America Osteoarthritis Drugs Sales Market Share by Country (2021-2026) Table 110. North America Osteoarthritis Drugs Sales Forecast by Country (2027-2032) & (kg) Table 111. North America Osteoarthritis Drugs Sales Market Share Forecast by Country (2027-2032) Table 112. North America Osteoarthritis Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 113. North America Osteoarthritis Drugs Market Size by Country (2021-2026) & (US$ Million) Table 114. North America Osteoarthritis Drugs Market Share by Country (2021-2026) Table 115. North America Osteoarthritis Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 116. North America Osteoarthritis Drugs Market Share Forecast by Country (2027-2032) Table 117. Europe Osteoarthritis Drugs Market Size Growth Rate (CAGR) by Country (kg): 2021 VS 2025 VS 2032 Table 118. Europe Osteoarthritis Drugs Sales by Country (2021-2026) & (kg) Table 119. Europe Osteoarthritis Drugs Sales Market Share by Country (2021-2026) Table 120. Europe Osteoarthritis Drugs Sales Forecast by Country (2027-2032) & (kg) Table 121. Europe Osteoarthritis Drugs Sales Market Share Forecast by Country (2027-2032) Table 122. Europe Osteoarthritis Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 123. Europe Osteoarthritis Drugs Market Size by Country (2021-2026) & (US$ Million) Table 124. Europe Osteoarthritis Drugs Market Share by Country (2021-2026) Table 125. Europe Osteoarthritis Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 126. Europe Osteoarthritis Drugs Market Share Forecast by Country (2027-2032) Table 127. Asia-Pacific Osteoarthritis Drugs Market Size Growth Rate (CAGR) by Country (kg): 2021 VS 2025 VS 2032 Table 128. Asia-Pacific Osteoarthritis Drugs Sales by Country (2021-2026) & (kg) Table 129. Asia-Pacific Osteoarthritis Drugs Sales Market Share by Country (2021-2026) Table 130. Asia-Pacific Osteoarthritis Drugs Sales Forecast by Country (2027-2032) & (kg) Table 131. Asia-Pacific Osteoarthritis Drugs Sales Market Share Forecast by Country (2027-2032) Table 132. Asia-Pacific Osteoarthritis Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 133. Asia-Pacific Osteoarthritis Drugs Market Size by Country (2021-2026) & (US$ Million) Table 134. Asia-Pacific Osteoarthritis Drugs Market Share by Country (2021-2026) Table 135. Asia-Pacific Osteoarthritis Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 136. Asia-Pacific Osteoarthritis Drugs Market Share Forecast by Country (2027-2032) Table 137. Latin America Osteoarthritis Drugs Market Size Growth Rate (CAGR) by Country (kg): 2021 VS 2025 VS 2032 Table 138. Latin America Osteoarthritis Drugs Sales by Country (2021-2026) & (kg) Table 139. Latin America Osteoarthritis Drugs Sales Market Share by Country (2021-2026) Table 140. Latin America Osteoarthritis Drugs Sales Forecast by Country (2027-2032) & (kg) Table 141. Latin America Osteoarthritis Drugs Sales Market Share Forecast by Country (2027-2032) Table 142. Latin America Osteoarthritis Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 143. Latin America Osteoarthritis Drugs Market Size by Country (2021-2026) & (US$ Million) Table 144. Latin America Osteoarthritis Drugs Market Share by Country (2021-2026) Table 145. Latin America Osteoarthritis Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 146. Latin America Osteoarthritis Drugs Market Share Forecast by Country (2027-2032) Table 147. Middle East and Africa Osteoarthritis Drugs Market Size Growth Rate (CAGR) by Country (kg): 2021 VS 2025 VS 2032 Table 148. Middle East and Africa Osteoarthritis Drugs Sales by Country (2021-2026) & (kg) Table 149. Middle East and Africa Osteoarthritis Drugs Sales Market Share by Country (2021-2026) Table 150. Middle East and Africa Osteoarthritis Drugs Sales Forecast by Country (2027-2032) & (kg) Table 151. Middle East and Africa Osteoarthritis Drugs Sales Market Share Forecast by Country (2027-2032) Table 152. Middle East and Africa Osteoarthritis Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 153. Middle East and Africa Osteoarthritis Drugs Market Size by Country (2021-2026) & (US$ Million) Table 154. Middle East and Africa Osteoarthritis Drugs Market Share by Country (2021-2026) Table 155. Middle East and Africa Osteoarthritis Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 156. Middle East and Africa Osteoarthritis Drugs Market Share Forecast by Country (2027-2032) Table 157. Key Raw Materials Table 158. Raw Materials Key Suppliers Table 159. Osteoarthritis Drugs Distributors List Table 160. Osteoarthritis Drugs Customers List Table 161. Research Programs/Design for This Report Table 162. Authors List of This Report Table 163. Secondary Sources Table 164. Primary Sources List of Figures Figure 1. Osteoarthritis Drugs Image Figure 2. Global Osteoarthritis Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Osteoarthritis Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Osteoarthritis Drugs Sales (2021-2032) & (kg) Figure 5. Injection Image Figure 6. Global Injection Sales YoY Growth (2021-2032) & (kg) Figure 7. External Image Figure 8. Global External Sales YoY Growth (2021-2032) & (kg) Figure 9. Oral Image Figure 10. Global Oral Sales YoY Growth (2021-2032) & (kg) Figure 11. Global Osteoarthritis Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Osteoarthritis Drugs Market Share by Type 2025 VS 2032 Figure 13. North America Osteoarthritis Drugs Sales Market Share in Volume by Type in 2025 Figure 14. North America Osteoarthritis Drugs Sales Market Share in Value by Type in 2025 Figure 15. Europe Osteoarthritis Drugs Sales Market Share in Volume by Type in 2025 Figure 16. Europe Osteoarthritis Drugs Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Osteoarthritis Drugs Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Osteoarthritis Drugs Sales Market Share in Value by Type in 2025 Figure 19. Latin America Osteoarthritis Drugs Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Osteoarthritis Drugs Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Osteoarthritis Drugs Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Osteoarthritis Drugs Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Osteoarthritis Drugs Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Online Pharmacies Image Figure 26. Global Online Pharmacies Sales YoY Growth (2021-2032) & (kg) Figure 27. Hospital Pharmacies Image Figure 28. Global Hospital Pharmacies Sales YoY Growth (2021-2032) & (kg) Figure 29. Retail Pharmacies Image Figure 30. Global Retail Pharmacies Sales YoY Growth (2021-2032) & (kg) Figure 31. Global Osteoarthritis Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Osteoarthritis Drugs Market Share by Application 2025 VS 2032 Figure 33. North America Osteoarthritis Drugs Sales Market Share in Volume by Application in 2025 Figure 34. North America Osteoarthritis Drugs Sales Market Share in Value by Application in 2025 Figure 35. Europe Osteoarthritis Drugs Sales Market Share in Volume by Application in 2025 Figure 36. Europe Osteoarthritis Drugs Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Osteoarthritis Drugs Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Osteoarthritis Drugs Sales Market Share in Value by Application in 2025 Figure 39. Latin America Osteoarthritis Drugs Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Osteoarthritis Drugs Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Osteoarthritis Drugs Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Osteoarthritis Drugs Sales Market Share in Value by Application in 2025 Figure 43. North America Osteoarthritis Drugs Sales by Country: 2021 VS 2025 VS 2032 (kg) Figure 44. North America Osteoarthritis Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Osteoarthritis Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Osteoarthritis Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Osteoarthritis Drugs Sales by Country: 2021 VS 2025 VS 2032 (kg) Figure 48. Europe Osteoarthritis Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Osteoarthritis Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Osteoarthritis Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Osteoarthritis Drugs Sales by Country: 2021 VS 2025 VS 2032 (kg) Figure 52. Asia-Pacific Osteoarthritis Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Osteoarthritis Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Osteoarthritis Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Osteoarthritis Drugs Sales by Country: 2021 VS 2025 VS 2032 (kg) Figure 56. Latin America Osteoarthritis Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Osteoarthritis Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Osteoarthritis Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Osteoarthritis Drugs Sales by Country: 2021 VS 2025 VS 2032 (kg) Figure 60. Middle East and Africa Osteoarthritis Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Osteoarthritis Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Osteoarthritis Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Osteoarthritis Drugs Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Osteoarthritis Drugs Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Injection
  • External
  • Oral
Applications
  • Online Pharmacies
  • Hospital Pharmacies
  • Retail Pharmacies
Companies covered
  • Flexion Therapeutics
  • GlaxoSmithKline
  • Pfizer
  • Eli Lilly
  • Johnson & Johnson
  • Sanofi
  • Abbott

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Osteoarthritis Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Osteoarthritis Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Osteoarthritis Drugs Market by Type
  6. 1.3.1 Injection
  7. 1.3.2 External
  8. 1.3.3 Oral
  9. 1.4 Global Osteoarthritis Drugs Market Size by Type
  10. 1.4.1 Global Osteoarthritis Drugs Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Osteoarthritis Drugs Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Osteoarthritis Drugs Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Osteoarthritis Drugs Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Osteoarthritis Drugs Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Osteoarthritis Drugs Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Osteoarthritis Drugs Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Osteoarthritis Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Osteoarthritis Drugs Industry Trends
  2. 2.2 Osteoarthritis Drugs Industry Drivers
  3. 2.3 Osteoarthritis Drugs Industry Opportunities and Challenges
  4. 2.4 Osteoarthritis Drugs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Osteoarthritis Drugs Revenue (2021-2026)
  2. 3.2 Global Top Players by Osteoarthritis Drugs Sales (2021-2026)
  3. 3.3 Global Top Players by Osteoarthritis Drugs Price (2021-2026)
  4. 3.4 Global Osteoarthritis Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Osteoarthritis Drugs Major Company Production Sites & Headquarters
  6. 3.6 Global Osteoarthritis Drugs Company, Product Type & Application
  7. 3.7 Global Osteoarthritis Drugs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Osteoarthritis Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Osteoarthritis Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Osteoarthritis Drugs Tier 1, Tier 2, and Tier 3
4 Osteoarthritis Drugs Regional Status and Outlook
  1. 4.1 Global Osteoarthritis Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Osteoarthritis Drugs Historic Market Size by Region
  3. 4.2.1 Global Osteoarthritis Drugs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Osteoarthritis Drugs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Osteoarthritis Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Osteoarthritis Drugs Forecasted Market Size by Region
  7. 4.3.1 Global Osteoarthritis Drugs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Osteoarthritis Drugs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Osteoarthritis Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Osteoarthritis Drugs by Application
  1. 5.1 Osteoarthritis Drugs Market by Application
  2. 5.1.1 Online Pharmacies
  3. 5.1.2 Hospital Pharmacies
  4. 5.1.3 Retail Pharmacies
  5. 5.2 Global Osteoarthritis Drugs Market Size by Application
  6. 5.2.1 Global Osteoarthritis Drugs Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Osteoarthritis Drugs Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Osteoarthritis Drugs Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Osteoarthritis Drugs Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Osteoarthritis Drugs Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Osteoarthritis Drugs Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Osteoarthritis Drugs Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Osteoarthritis Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Flexion Therapeutics
  2. 6.1.1 Flexion Therapeutics Company Information
  3. 6.1.2 Flexion Therapeutics Business Overview
  4. 6.1.3 Flexion Therapeutics Osteoarthritis Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Flexion Therapeutics Osteoarthritis Drugs Product Portfolio
  6. 6.1.5 Flexion Therapeutics Recent Developments
  7. 6.2 GlaxoSmithKline
  8. 6.2.1 GlaxoSmithKline Company Information
  9. 6.2.2 GlaxoSmithKline Business Overview
  10. 6.2.3 GlaxoSmithKline Osteoarthritis Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 GlaxoSmithKline Osteoarthritis Drugs Product Portfolio
  12. 6.2.5 GlaxoSmithKline Recent Developments
  13. 6.3 Pfizer
  14. 6.3.1 Pfizer Company Information
  15. 6.3.2 Pfizer Business Overview
  16. 6.3.3 Pfizer Osteoarthritis Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Pfizer Osteoarthritis Drugs Product Portfolio
  18. 6.3.5 Pfizer Recent Developments
  19. 6.4 Eli Lilly
  20. 6.4.1 Eli Lilly Company Information
  21. 6.4.2 Eli Lilly Business Overview
  22. 6.4.3 Eli Lilly Osteoarthritis Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Eli Lilly Osteoarthritis Drugs Product Portfolio
  24. 6.4.5 Eli Lilly Recent Developments
  25. 6.5 Johnson & Johnson
  26. 6.5.1 Johnson & Johnson Company Information
  27. 6.5.2 Johnson & Johnson Business Overview
  28. 6.5.3 Johnson & Johnson Osteoarthritis Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Johnson & Johnson Osteoarthritis Drugs Product Portfolio
  30. 6.5.5 Johnson & Johnson Recent Developments
  31. 6.6 Sanofi
  32. 6.6.1 Sanofi Company Information
  33. 6.6.2 Sanofi Business Overview
  34. 6.6.3 Sanofi Osteoarthritis Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Sanofi Osteoarthritis Drugs Product Portfolio
  36. 6.6.5 Sanofi Recent Developments
  37. 6.7 Abbott
  38. 6.7.1 Abbott Company Information
  39. 6.7.2 Abbott Business Overview
  40. 6.7.3 Abbott Osteoarthritis Drugs Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Abbott Osteoarthritis Drugs Product Portfolio
  42. 6.7.5 Abbott Recent Developments
7 North America by Country
  1. 7.1 North America Osteoarthritis Drugs Sales by Country
  2. 7.1.1 North America Osteoarthritis Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Osteoarthritis Drugs Sales by Country (2021-2026)
  4. 7.1.3 North America Osteoarthritis Drugs Sales Forecast by Country (2027-2032)
  5. 7.2 North America Osteoarthritis Drugs Market Size by Country
  6. 7.2.1 North America Osteoarthritis Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Osteoarthritis Drugs Market Size by Country (2021-2026)
  8. 7.2.3 North America Osteoarthritis Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Osteoarthritis Drugs Sales by Country
  2. 8.1.1 Europe Osteoarthritis Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Osteoarthritis Drugs Sales by Country (2021-2026)
  4. 8.1.3 Europe Osteoarthritis Drugs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Osteoarthritis Drugs Market Size by Country
  6. 8.2.1 Europe Osteoarthritis Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Osteoarthritis Drugs Market Size by Country (2021-2026)
  8. 8.2.3 Europe Osteoarthritis Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Osteoarthritis Drugs Sales by Country
  2. 9.1.1 Asia-Pacific Osteoarthritis Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Osteoarthritis Drugs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Osteoarthritis Drugs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Osteoarthritis Drugs Market Size by Country
  6. 9.2.1 Asia-Pacific Osteoarthritis Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Osteoarthritis Drugs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Osteoarthritis Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Osteoarthritis Drugs Sales by Country
  2. 10.1.1 South America Osteoarthritis Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Osteoarthritis Drugs Sales by Country (2021-2026)
  4. 10.1.3 South America Osteoarthritis Drugs Sales Forecast by Country (2027-2032)
  5. 10.2 South America Osteoarthritis Drugs Market Size by Country
  6. 10.2.1 South America Osteoarthritis Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Osteoarthritis Drugs Market Size by Country (2021-2026)
  8. 10.2.3 South America Osteoarthritis Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Osteoarthritis Drugs Sales by Country
  2. 11.1.1 Middle East and Africa Osteoarthritis Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Osteoarthritis Drugs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Osteoarthritis Drugs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Osteoarthritis Drugs Market Size by Country
  6. 11.2.1 Middle East and Africa Osteoarthritis Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Osteoarthritis Drugs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Osteoarthritis Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Osteoarthritis Drugs Value Chain Analysis
  2. 12.1.1 Osteoarthritis Drugs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Osteoarthritis Drugs Production Mode & Process
  7. 12.2 Osteoarthritis Drugs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Osteoarthritis Drugs Distributors
  10. 12.2.3 Osteoarthritis Drugs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst